VistaGen Therapeutics (VTGN)

• Market cap: $26.1M
• 1 day: -2.39%
• 5 days: -6.77%
• 1 month: -85.06%
• 3 months: -81.35%
• 6 months: -66.9%
• Year to date: -80.06%
• 1 year: -77.56%
• 5 years: -98.86%
• 10 years: -99.46%
• Sector: Healthcare
• Industry: Biotechnology

About: Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Employees: 59